Keep the Six Protected Classes, protected

Medicare Part D has been successfully providing seniors with comprehensive drug coverage for more than a decade, and one of the cornerstones of the program has been to ensure the sickest and most vulnerable patients have access to the clinically critical medicines they rely on.

New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers

The whitepaper identifies several problems in applying ICER’s reports to inform coverage decisions by private payers

What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?

Right now, Congress has the opportunity to make two small fixes that will protect seniors in the Medicare Part D donut hole and save them money on out-of-pocket costs for their medicines

How much do you know about Medicare Part B?

As conversations about Medicare Part B continue, it’s important to get the facts straight and ensure they are being put in context

Diversity of thought fuels next generation of breakthroughs

This month, PhRMA is proud to join with our member companies to celebrate Lesbian, Gay, Bisexual and Transgender (LGBT) PRIDE Month

Guest post: Ensuring communities have a seat at the table: The importance of diversity in clinical trials

With Asian Pacific American Heritage Month underway, we’re taking some time to celebrate the diversity within our community and to acknowledge the many contributions Asian Americans (AAs), Native Hawaiians and Pacific Islanders (NHPIs) have made to ensure a better tomorrow for all Americans

Improve women’s health by treating the disease, not the pain

Millions of women suffer from chronic, painful conditions that lack sufficient treatment options

PPA celebrates 13 years of helping patients access their medicines

Since launching in 2005, PPA has connected more than 10 million people to patient assistance programs (PAPs), which serve as critical safety nets for the millions of Americans who lack health insurance or whose insurance does not sufficiently cover the cost of the medicines they need

Improving care quality by engaging patients in shared decision making

With the rapid movement towards value-based payment and delivery in health care, it is critical not to leave one of the key players behind: the patient

Ask About Adherence: New study demonstrates how adherence programs can improve health outcomes for patients with cardiovascular disease

Recently, Health Affairs published a study that examined medication synchronization programs, which allow patients to collect all their medications in a single visit to the pharmacy, and their impact on cardiovascular medication adherence among Medicare beneficiaries

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

VIDEO: PhRMA CEO discusses industry response to opioid crisis on Mornings with Maria

A critical opportunity to prevent prescription drug abuse

12 years of the Partnership of Prescription Assistance

Medicare Monday: A discussion on affordability and access to medicines

17 years (and more) of medical discoveries

How do multiple sclerosis patients define value?

ICYMI: New era of medicine initiative kicks off in Boston

Biopharmaceutical industry’s success reducing disparities for African Americans